Rakuten Medical Stock

rakuten-med.comHealthcareFounded: 2013Funding to Date: $655.92MM

Rakuten Medical is a biotechnology company focused on developing precision, cell-targeting investigational therapies on its IlluminoxTM platform, which, in pre-clinical studies have shown to lead to rapid and selective cell killing and tumor necrosis.

Register for Details

For more details on financing and valuation for Rakuten Medical, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Rakuten Medical.

Register Today

Team

Management Team

Takashi Toraishi Ph.D
President & Chief Operating Officer
Hiroshi Mikitani
Chief Executive Officer & Chairman
Miguel Garcia-Guzman Ph.D
Vice Chairman & CSO
Merrill Biel Ph.D
Chief Medical Officer
Carlos Garcia
Chief Technology Officer
Agatha Martindale
Vice President, Finance

Board Members

Hiroshi Mouri
Hiroshi Mikitani
Miguel Garcia-Guzman Ph.D

Other companies like Rakuten Medical in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
 
 
Sector
Last Round Est. Valuation
$317.32MM
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$1.59B
Sector
Last Round Est. Valuation
$4.26B
Sector
 
 

News

Rakuten Medical, a San Mateo CA-based biotechnology company focused on developing and commercializing innovative oncology products for multiple indications, raised $166M in Series D funding